Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.9M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
5.56M
-
Shares change
-
+282K
-
Total reported value, excl. options
-
$12.3M
-
Value change
-
+$345K
-
Number of buys
-
17
-
Number of sells
-
-20
-
Price
-
$2.21
Significant Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q2 2024
66 filings reported holding ANIX - Anixa Biosciences Inc - Common Stock as of Q2 2024.
Anixa Biosciences Inc - Common Stock (ANIX) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.56M shares
of 37.9M outstanding shares and own 14.67% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.39M shares), D.A. DAVIDSON & CO. (736K shares), Laird Norton Wetherby Trust Company, LLC (604K shares), UBS Group AG (531K shares), MISSION WEALTH MANAGEMENT, LP (502K shares), GEODE CAPITAL MANAGEMENT, LLC (331K shares), BANK OF AMERICA CORP /DE/ (217K shares), Long Focus Capital Management, LLC (166K shares), BlackRock Inc. (160K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (112K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.